Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Abstract Non-alcoholic fatty liver disease (NAFLD) is associated with a substantial increased risk of atherosclerotic cardiovascular disease (ASCVD), which is partly related to dyslipidemia and low HDL-C level. The cardioprotective activity of HDL in the body is closely connected to its role in prom...
Guardado en:
Autores principales: | Reza Fadaei, Hossein Poustchi, Reza Meshkani, Nariman Moradi, Taghi Golmohammadi, Shahin Merat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7bc83b5eb5d54df5bca1e284d6a04417 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Mengdie Luo, et al.
Publicado: (2017) -
The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation
por: Asuka Minami-Takano, et al.
Publicado: (2021) -
Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.
por: Susan Kühnast, et al.
Publicado: (2013) -
HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
por: Ruth Blanco-Rojo, et al.
Publicado: (2017) -
Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: William Hancock-Cerutti, et al.
Publicado: (2021)